Literature DB >> 3041014

Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus.

P J Provost, P M Keller, F S Banker, B J Keech, H J Klein, R S Lowe, D H Morton, A H Phelps, W J McAleer, R W Ellis.   

Abstract

The common marmoset, Callithrix jacchus, can be infected with human varicella-zoster virus (VZV), both wild-type strain KMcC and attenuated vaccine strain Oka/Merck. Infection was accomplished with either whole-cell-associated or cell extract VZV by combined oral-nasal-conjunctival application and was characterized by substantial and persistent anti-VZV antibody responses. The infectivity of VZV for marmosets was destroyed by treatment of inocula with heat or UV light. Diluted inocula with as few as 40 PFU/ml were infectious for marmosets. The lungs were demonstrated to be a major site of viral replication; both the presence of viral antigens and signs of pneumonia were demonstrated in lung tissues. Four serial passages of VZV KMcC were carried out in C. jacchus by a process of in vitro isolation and culturing of VZV from infected lung tissue and reapplication of the cultured isolates to fresh animals. The isolated viruses were identified as VZV both serologically and by restriction endonuclease analyses. The C. jacchus infectivity model should prove useful for determining the efficacy of subunit and live recombinant VZV vaccines as well as for the study of zoster.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041014      PMCID: PMC255866          DOI: 10.1128/JVI.61.10.2951-2955.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Enzyme-linked immunosorbent assay for susceptibility to varicella.

Authors:  Z Shehab; P A Brunell
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

2.  Varicella-zoster virus as a live vector for the expression of foreign genes.

Authors:  R S Lowe; P M Keller; B J Keech; A J Davison; Y Whang; A J Morgan; E Kieff; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

3.  Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus.

Authors:  P M Keller; A J Davison; R S Lowe; M W Riemen; R W Ellis
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

4.  Use of a bacterial expression vector to map the varicella-zoster virus major glycoprotein gene, gC.

Authors:  R W Ellis; P M Keller; R S Lowe; R A Zivin
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Varicella-zoster virus infection of strain 2 guinea pigs.

Authors:  M G Myers; L R Stanberry; B J Edmond
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

6.  Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus.

Authors:  P M Keller; A J Davison; R S Lowe; C D Bennett; R W Ellis
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

7.  Inoculation of guinea pigs with varicella-zoster virus via the respiratory route.

Authors:  M A Walz-Cicconi; R M Rose; G J Dammin; T H Weller
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Experimental infection and immune response of guinea pigs with varicella-zoster virus.

Authors:  Y Matsunaga; K Yamanishi; M Takahashi
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeys.

Authors:  Y Asano; P Albrecht; D E Behr; B J Neff; J H Vickers; S C Rastogi
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

10.  Immunogenicity of wild and attenuated varicella-zoster virus strains in pygmy marmosets.

Authors:  Y Asano; P Albrecht; J H Vickers
Journal:  Proc Soc Exp Biol Med       Date:  1983-09
View more
  7 in total

Review 1.  Viruses in chronic progressive neurologic disease.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Mult Scler       Date:  2018-01       Impact factor: 6.312

2.  Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Authors:  Christine Meyer; Flora Engelmann; Nicole Arnold; David L Krah; Jan ter Meulen; Kristen Haberthur; Jesse Dewane; Ilhem Messaoudi
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

3.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

Review 4.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

Review 5.  Animal models of varicella zoster virus infection.

Authors:  Kristen Haberthur; Ilhem Messaoudi
Journal:  Pathogens       Date:  2013-05-13

6.  Monoclonal antibodies from Epstein-Barr virus-transformed lymphocytes of common marmosets (Callithrix jacchus) immune to malaria.

Authors:  D A Johnston; A M Knight; B A Naylor; N Wedderburn; G H Mitchell
Journal:  J Immunol Methods       Date:  1990-03-09       Impact factor: 2.303

7.  Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization.

Authors:  Emily Leibovitch; Jillian E Wohler; Sheila M Cummings Macri; Kelsey Motanic; Erin Harberts; María I Gaitán; Pietro Maggi; Mary Ellis; Susan Westmoreland; Afonso Silva; Daniel S Reich; Steven Jacobson
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.